General Home Investors News

Olanzapine LAI: No PDSS Observed After Completion of c.99% of the Targeted Injections for Submission

By MedincellSeptember 5, 2024September 19th, 2024No Comments

Olanzapine LAI: No PDSS Observed After Completion of c.99% of the Targeted Injections for Submission

September 5, 2024

Previous PostPresentation at the H.C. Wainwright 26th Annual Global Investment Conference (New York, September 9 to 11)
Next PostProgress in the Development of the Products Portfolio and the R&D Pipeline

Better medicine for all

Website by ScreenUp